Cefixime for Oral Suspension USP, 100mg/5mL, Rx Only, Manufactured for: Lupin Pharmaceutical, Inc. Baltimore, Maryland 21202 United States, Manufactured by: Lupin Limited Mandideep 462 046 INDIA, NDC 68180-405-01
Published April 29, 2020 · Recall initiated: April 15, 2020
Summary
FDA records drug Class II recall D-1252-2020, published April 29, 2020 and initiated April 15, 2020. Recalling firm: Lupin Pharmaceuticals Inc.; Status: Terminated; Reported quantity: 4,518 bottles; Lot: Lot #: F800779, Expiry 4/2020. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Subpotent Drug: low out of specification (OOS) test result observed in long term stability study.
What to do
Voluntary: Firm initiated · Letter
Get an email if CEFIXIME has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- CEFIXIME
- Manufacturer
- Lupin Pharmaceuticals Inc.
- Distributor
- Nationwide with the United States and Puerto Rico.
- UPC
- 0368180423089
- Lot
- Lot #: F800779, Expiry 4/2020
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDACefixime for Oral Suspension USP, 100 mg/5 mL, 50 mL bottle, Rx only, Manufactured for: Lupin Pharmaceuticals,September 4, 2024
- FDACefixime for Oral Suspension USP 200 mg/5 mL (50 mL Pack size), Powder for oral suspension, Rx only,June 26, 2024
- FDACefixime for Oral Suspension 100mg/5mL, 50 mL bottle, Rx Only, Manufactured for: Lupin Pharmaceuticals, Inc.,February 7, 2024
- FDACefixime Capsules, 400 mg, 50-count bottles, Rx only, Manufactured by: Alkem Laboratories Ltd., Mumbai, India,January 12, 2022
- FDAPEPPERMINT LIP MOISTURIZER (oxybenzone (4%) and Octinoxate (7%) SPF 15, 4.2 g tube, labeled as a) Bimark Inc.,April 29, 2020
- FDAEnoki Mushroom; 7.5oz (200g); UPC #831211204181; packed in clear plastic bag with green label; imported fromApril 29, 2020
Questions about this recall
Was Cefixime for Oral Suspension USP, 100mg/5mL, Rx Only, Manufactured for: Lupin Pharmaceutical, Inc. Baltimore, Maryland 21202 United States, Manufactured by: Lupin Limited Mandideep 462 046 INDIA, NDC 68180-405-01 recalled?
Yes. FDA published recall D-1252-2020 on April 29, 2020. Reported hazard: Subpotent Drug: low out of specification (OOS) test result observed in long term stability study.
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: CEFIXIME. UPC: 0368180423089.